Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | SCF | 58.0 | 44 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 66.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 68.0 | 53 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 46.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 44.5 | 82 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 49.0 | 65 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 52.0 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 61.0 | 55 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | SCF | 63.5 | 56 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 54.0 | 45 | |
N2645 | TNF-a | 100 | ng/mL | 4 | SCF | 53.0 | 67 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | SCF | 54.5 | 54 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | SCF | 47.0 | 43 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | SCF | 66.0 | 36 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | SCF | 60.0 | 53 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | SCF | 48.0 | 63 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | SCF | 47.0 | 57 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | SCF | 50.0 | 61 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | SCF | 54.5 | 72 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | SCF | 59.5 | 54 | ||||
RA2159 | 4 | SCF | 66.0 | 45 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | SCF | 43.0 | 60 | ||||
N2645 | 4 | SCF | 46.5 | 56 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | SCF | 54.0 | 53 | ||||
RA2708 | 4 | SCF | 47.0 | 37 |